Pathology of experimental bladder cancer in rodents

Research output: Chapter in Book/Report/Conference proceedingChapter

55 Citations (Scopus)

Abstract

The lower urinary tract of experimental animals has been actively studied since the search began for etiological factors in bladder carcinogenesis following the report in 1895 by Rehn that workers in the German aniline dye industry developed bladder cancer. The induction of bladder cancer in dogs by 2-naphthylamine, reported by Hueper and colleagues in 1938, established the experimental basis of bladder carcinogenesis. Induction in rodents was first observed following the oral administration of 2-acetylaminofluorene (AAF) to rats in 1941. Although of considerable usefulness in experimental bladder carcinogenesis research, AAF is a pluripotent carcinogen, inducing tumors of several tissues in addition to the urinary bladder, particularly the liver, breast, and ear duct. 1, 2 In the 1960s and early 1970s, organ-specific, chemically defined bladder carcinogens were discovered for rodents, including N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) administered in the drinking water, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) administered in the diet, and N-methyl-N-nitrosourea (MNU) instilled directly into the bladder lumen. These chemicals and their application provided the readily available, reproducible models necessary for detailed studies of the biochemical, pathobiological, and immunological mechanisms involved in the etiology and pathogenesis of bladder cancer.

Original languageEnglish (US)
Title of host publicationPathology of Bladder Cancer
PublisherCRC Press
Pages1-40
Number of pages40
ISBN (Electronic)9781351359580
ISBN (Print)9781138505643
DOIs
StatePublished - Jan 1 2017

Fingerprint

Urinary Bladder Neoplasms
Rodentia
Urinary Bladder
Pathology
2-Acetylaminofluorene
Carcinogenesis
Carcinogens
FANFT
Butylhydroxybutylnitrosamine
2-Naphthylamine
Methylnitrosourea
Urinary Tract
Drinking Water
Ear
Oral Administration
Industry
Breast
Coloring Agents
Dogs
Diet

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pathology of experimental bladder cancer in rodents. / Cohen, Samuel Monroe.

Pathology of Bladder Cancer. CRC Press, 2017. p. 1-40.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cohen, Samuel Monroe. / Pathology of experimental bladder cancer in rodents. Pathology of Bladder Cancer. CRC Press, 2017. pp. 1-40
@inbook{c9f5da9177814127a47f4506c558bbae,
title = "Pathology of experimental bladder cancer in rodents",
abstract = "The lower urinary tract of experimental animals has been actively studied since the search began for etiological factors in bladder carcinogenesis following the report in 1895 by Rehn that workers in the German aniline dye industry developed bladder cancer. The induction of bladder cancer in dogs by 2-naphthylamine, reported by Hueper and colleagues in 1938, established the experimental basis of bladder carcinogenesis. Induction in rodents was first observed following the oral administration of 2-acetylaminofluorene (AAF) to rats in 1941. Although of considerable usefulness in experimental bladder carcinogenesis research, AAF is a pluripotent carcinogen, inducing tumors of several tissues in addition to the urinary bladder, particularly the liver, breast, and ear duct. 1, 2 In the 1960s and early 1970s, organ-specific, chemically defined bladder carcinogens were discovered for rodents, including N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) administered in the drinking water, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) administered in the diet, and N-methyl-N-nitrosourea (MNU) instilled directly into the bladder lumen. These chemicals and their application provided the readily available, reproducible models necessary for detailed studies of the biochemical, pathobiological, and immunological mechanisms involved in the etiology and pathogenesis of bladder cancer.",
author = "Cohen, {Samuel Monroe}",
year = "2017",
month = "1",
day = "1",
doi = "10.1201/9780203711163",
language = "English (US)",
isbn = "9781138505643",
pages = "1--40",
booktitle = "Pathology of Bladder Cancer",
publisher = "CRC Press",

}

TY - CHAP

T1 - Pathology of experimental bladder cancer in rodents

AU - Cohen, Samuel Monroe

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The lower urinary tract of experimental animals has been actively studied since the search began for etiological factors in bladder carcinogenesis following the report in 1895 by Rehn that workers in the German aniline dye industry developed bladder cancer. The induction of bladder cancer in dogs by 2-naphthylamine, reported by Hueper and colleagues in 1938, established the experimental basis of bladder carcinogenesis. Induction in rodents was first observed following the oral administration of 2-acetylaminofluorene (AAF) to rats in 1941. Although of considerable usefulness in experimental bladder carcinogenesis research, AAF is a pluripotent carcinogen, inducing tumors of several tissues in addition to the urinary bladder, particularly the liver, breast, and ear duct. 1, 2 In the 1960s and early 1970s, organ-specific, chemically defined bladder carcinogens were discovered for rodents, including N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) administered in the drinking water, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) administered in the diet, and N-methyl-N-nitrosourea (MNU) instilled directly into the bladder lumen. These chemicals and their application provided the readily available, reproducible models necessary for detailed studies of the biochemical, pathobiological, and immunological mechanisms involved in the etiology and pathogenesis of bladder cancer.

AB - The lower urinary tract of experimental animals has been actively studied since the search began for etiological factors in bladder carcinogenesis following the report in 1895 by Rehn that workers in the German aniline dye industry developed bladder cancer. The induction of bladder cancer in dogs by 2-naphthylamine, reported by Hueper and colleagues in 1938, established the experimental basis of bladder carcinogenesis. Induction in rodents was first observed following the oral administration of 2-acetylaminofluorene (AAF) to rats in 1941. Although of considerable usefulness in experimental bladder carcinogenesis research, AAF is a pluripotent carcinogen, inducing tumors of several tissues in addition to the urinary bladder, particularly the liver, breast, and ear duct. 1, 2 In the 1960s and early 1970s, organ-specific, chemically defined bladder carcinogens were discovered for rodents, including N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) administered in the drinking water, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) administered in the diet, and N-methyl-N-nitrosourea (MNU) instilled directly into the bladder lumen. These chemicals and their application provided the readily available, reproducible models necessary for detailed studies of the biochemical, pathobiological, and immunological mechanisms involved in the etiology and pathogenesis of bladder cancer.

UR - http://www.scopus.com/inward/record.url?scp=85053335139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053335139&partnerID=8YFLogxK

U2 - 10.1201/9780203711163

DO - 10.1201/9780203711163

M3 - Chapter

AN - SCOPUS:85053335139

SN - 9781138505643

SP - 1

EP - 40

BT - Pathology of Bladder Cancer

PB - CRC Press

ER -